Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Yuanying
Contact Yuanying, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
Trilaciclib triggers a neutrophil-related immune response and sensitizes non-small cell lung cancer to anti-PD-1 therapy
Keywords non-small cell lung cancer trilaciclib neutrophils senescence cGAS-STING pathway immune checkpoint blockade Introduction Lung cancer, particularly non-small cell lung cancer (NSCLC), remains a leading cause of cancer-related mortality.1,2 Although immunotherapy improves survival in advanced NSCLC, the overall objective response rate to single-agent immune checkpoint inhibitors remains less than 20%.3,4,5,6 Based on these considerations, the combination of immunotherapy with...
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Yuanying
Contact Yuanying, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack